Allianz Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
362,546
+168,955
| +87% | +$6.09M | 0.02% | 617 |
|
|
2025
Q1 | $6.03M | Sell |
193,591
-356,968
| -65% | -$11.1M | 0.01% | 828 |
|
|
2024
Q4 | $14M | Sell |
550,559
-208,864
| -28% | -$5.33M | 0.02% | 582 |
|
|
2024
Q3 | $21.5M | Buy |
759,423
+553,550
| +269% | +$15.7M | 0.03% | 473 |
|
|
2024
Q2 | $5.43M | Buy |
205,873
+57,870
| +39% | +$1.53M | 0.01% | 814 |
|
|
2024
Q1 | $4.49M | Buy |
148,003
+82,921
| +127% | +$2.52M | 0.01% | 845 |
|
|
2023
Q4 | $1.83M | Sell |
65,082
-53,802
| -45% | -$1.51M | ﹤0.01% | 1076 |
|
|
2023
Q3 | $3.23M | Buy |
118,884
+33,628
| +39% | +$913K | 0.01% | 883 |
|
|
2023
Q2 | $2.62M | Sell |
85,256
-30,973
| -27% | -$952K | ﹤0.01% | 915 |
|
|
2023
Q1 | $4.19M | Sell |
116,229
-17,092
| -13% | -$616K | 0.01% | 835 |
|
|
2022
Q4 | $5.27M | Buy |
133,321
+9,648
| +8% | +$381K | 0.01% | 759 |
|
|
2022
Q3 | $4.97M | Buy |
123,673
+66,291
| +116% | +$2.66M | 0.01% | 779 |
|
|
2022
Q2 | $2.41M | Buy |
57,382
+33,977
| +145% | +$1.43M | ﹤0.01% | 1253 |
|
|
2022
Q1 | $911K | Sell |
23,405
-4,512
| -16% | -$176K | ﹤0.01% | 1586 |
|
|
2021
Q4 | $1.11M | Buy |
27,917
+11,032
| +65% | +$440K | ﹤0.01% | 1575 |
|
|
2021
Q3 | $610K | Buy |
16,885
+6,662
| +65% | +$241K | ﹤0.01% | 1712 |
|
|
2021
Q2 | $419K | Buy |
10,223
+5,260
| +106% | +$216K | ﹤0.01% | 1728 |
|
|
2021
Q1 | $216K | Hold |
4,963
| – | – | ﹤0.01% | 1845 |
|
|
2020
Q4 | $248K | Buy |
+4,963
| New | +$248K | ﹤0.01% | 1758 |
|